Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Poland

Poland Articles

Industry

BMI View: The acquisition of companies with products outside of normal medical healthcare sales channels will protect Sanofi-Aventis from the tightening of public sector healthcare... 2010-07-22


Industry

Pharmaceutical sales patterns in Poland in Q110 showed mixed results, with major contractions on an annual basis in January, followed by a return to strong market growth towards the... 2010-04-14


Industry

As part of reforms to Poland's pricing and reimbursement system, the Ministry of Health is considering introducing a 3% tax on returns from reimbursed medicines. The levy would be... 2010-04-13


More ARTICLES

BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,... 2010-03-15


Companies

The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent... 2010-03-11


Industry

BMI calculates that Poland's pharmaceutical market grew by 10.5% on a local currency basis in 2009, reaching a value of PLN30.25bn (US$9.85bn) at retail prices. This marks a slightly... 2010-01-12


Companies

GlaxoSmithKline (GSK) is to transfer production of benign prostatic hyperplasia treatment Avodart (dutasteride) from France to Poland, in an effort to optimise manufacturing costs.... 2010-01-11


Industry

Poland's pricing and reimbursement system is similar in structure to many others in Central and Eastern Europe (CEE), but among the most rigorous in terms controlling expenditure.... 2010-01-06

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries